Response to ''Validating discovery in literature-based discovery"

Journal of Biomedical Informatics

Volumn 40, Issue 4, 2007, Pages 450-452

  Pratt, Wanda ^a   Yetisgen Yildiz, Meliha ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID;

ALZHEIMER DISEASE; COMPUTER SYSTEM; HEALTH PRACTITIONER; LETTER; MEDLINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; SCIENTIFIC LITERATURE;

EID: 34547570881     PISSN: 15320464     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbi.2007.07.002     Document Type: Letter

References (16)

1. Cochrane Collaboration "Levels of Evidence", http://www.cochrane.org/consumers/sysrev.htm#levels; 2007 [accessed 2.7.07].
2. Yetisgen-Yildiz M., and Pratt W. Using statistical and knowledge-based approaches for literature-based discovery. J Biomed Inform 39 6 (2006) 600-611
3. Milton N.G. Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neurosci Lett 332 2 (2002) 127-130
4. Fernandez-Ruiz J., Lastres-Becker I., Cabranes A., Gonzalez S., and Ramos J.A. Endocannabinoids and basal ganglia functionality. Prostaglandins Leukot Essent Fatty Acids 66 2-3 (2002) 257-267
5. Lagalwar S., Bordayo E.Z., Hoffmann K.L., Fawcett J.R., and Frey II W.H. Anandamides inhibit binding to the muscarinic acetylcholine receptor. J Mol Neurosci 13 1-2 (1999) 55-61
6. Pazos M.R., Nunez E., Benito C., et al. Role of the endocannabinoid system in Alzheimer's disease: new perspectives. Life Sci 75 16 (2004) 1907-1915
7. Marsicano G., Moosmann B., Hermann H., et al. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80 3 (2002) 448-456
8. Sang C.N., Ramadan N.M., Chappell A.S., et al. A double-blind, placebo-controlled study to investigate the efficacy and tolerability of 1.2 mg/kg intravenous LY293558 versus 6 mg subcutaneous sumatriptan versus placebo in patients with an acute migraine attack. Neurology 56 8 (2001) A218 (Suppl. 3)
9. Ramadan N.M. The link between glutamate and migraine. CNS Spectr 8 6 (2003) 446-449
10. Pratt W, Yetisgen-Yildiz M. A study of biomedical concept identification: MetaMap vs. people. Proceedings of the American Medical Informatics Association Fall Symposium (AMIA'03), 2003:529-533.
11. Yetisgen-Yildiz, M Pratt W. Evaluation of Literature-based discovery systems. In: Bruza PD, Weeber, M, Editors. Literature-based discovery. Springer (in press).
12. Skeels M, Henning K, Yetisgen-Yildiz M, Pratt W. Interaction design for literature-based discovery. In: Proceedings of the International Conference for Human-Computer Interaction (CHI'05). Portland, 2005.
13. Swanson D.R. Migraine and magnesium: eleven neglected connections. Perspect Biol Med 31 (1988) 526-557
14. Swanson DR. Somatomedin C and arginine; implicit connections between mutually-isolated literatures. Perspect Biol Med 1990;33:157-186.
15. Smalheiser N.R., and Swanson D.R. Indomethacin and Alzheimer s disease. Neurology 46 (1996) 583
16. Smalheiser N.R., and Swanson D.R. Linking estrogen to Alzheimer's disease: an informatics approach. Neurology 47 (1996) 809-810